EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (LEVOCETIRIZINE 5 MG).

Trial Profile

EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (LEVOCETIRIZINE 5 MG).

Recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Jun 2012

At a glance

  • Drugs Levocetirizine; Levomequitazine
  • Indications Perennial allergic rhinitis; Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jun 2012 Actual initiation date changed from 13 Feb 2008 to 4 Dec 2007 as reported by European Clinical Trials Database.
    • 09 Jun 2012 Planned end date changed from 13 May 2010 to 4 Mar 2011 as reported by European Clinical Trials Database.
    • 27 Aug 2011 This trial is recruiting in Spain and Czech Republic, discontinued in Austria, United Kingdom, Estonia, Lithuania and Finland and has completed in Latvia.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top